| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/03/2005 | US20050025715 Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders |
| 02/03/2005 | DE10057976B4 Verfahren zur Herstellung von Pektinhydrolyseprodukten A process for producing pectin hydrolysis products |
| 02/03/2005 | CA2536644A1 Antibodies and uses thereof |
| 02/03/2005 | CA2533707A1 Treatment of lesions of the soft tissues |
| 02/03/2005 | CA2533367A1 Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 02/03/2005 | CA2533358A1 Antibiotic product, use and formulation thereof |
| 02/03/2005 | CA2533352A1 Bacteriophage-containing therapeutic agents |
| 02/03/2005 | CA2533292A1 Antibiotic product, use and formulation thereof |
| 02/03/2005 | CA2533178A1 Antibiotic product, use and formulation thereof |
| 02/03/2005 | CA2532370A1 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | CA2532102A1 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | CA2532084A1 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 02/03/2005 | CA2532035A1 Fugetactic proteins, compositions and methods of use |
| 02/03/2005 | CA2531491A1 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | CA2517600A1 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/02/2005 | EP1502949A1 Antimicrobial polypeptide and utizliation thereof |
| 02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1502586A1 Preparations for the application of anti-inflammatory agents |
| 02/02/2005 | EP1502508A2 Synergistic microbicidal combinations |
| 02/02/2005 | EP1502109A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501921A1 Improved viral purification methods |
| 02/02/2005 | EP1501870A2 Rsv proteins, antibodies, compositions, methods and uses |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501850A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 02/02/2005 | EP1501847A2 11-deoxy azalide antibacterials |
| 02/02/2005 | EP1501846A1 Tricyclic macrolide antibacterial compounds |
| 02/02/2005 | EP1501845A1 Antibacterial compounds with improved pharmacokinetic profiles |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501833A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501822A1 Phthalazinone derivatives |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501795A1 Cinnamic acid amides |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501550A1 Non-viral gene delivery system |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501537A1 Mannose binding lectin and uses thereof |
| 02/02/2005 | EP1501527A1 Use of mastic and its components for the control of microbial infections |
| 02/02/2005 | EP1501521A1 Long acting compositions comprising zidovudine and lamivudine |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501497A2 Catechin multimers as therapeutic drug delivery agents |
| 02/02/2005 | EP1501495A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
| 02/02/2005 | EP1501492A1 ANTI- i RHINOVIRUS /i ACTIVE AGENTS |
| 02/02/2005 | EP1501490A2 Methods of simultaneously treating mucositis and fungal infection |
| 02/02/2005 | EP1501479A1 Capsules for dry powder inhalers and methods of making and using same |
| 02/02/2005 | EP1501478A1 Warming and nonirritating anhydrous lubricant compositions |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1379257A4 Prodrugs of anticancer agents employing substituted aromatic acids |
| 02/02/2005 | EP1373267B1 Non-nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1256588B1 Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both |
| 02/02/2005 | EP1242395B1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 02/02/2005 | EP1131104B1 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 02/02/2005 | EP1124779B1 Vitamin d analogues |
| 02/02/2005 | EP1119248B1 Hydroxystilbene compounds used as microbicidal active substances |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0606437B1 Non-shedding live herpesvirus vaccine |
| 02/02/2005 | CN1575339A Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575334A Pathogen for bacterial poultry disease |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575280A Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1575166A Preventive and/or therapeutic agent for viral infection |
| 02/02/2005 | CN1575165A Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1572874A Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 02/02/2005 | CN1572328A Vaccine against SARS virogene and its preparation method and use |
| 02/02/2005 | CN1572324A Adjuvant composition |
| 02/02/2005 | CN1572323A Vaccine against SARS virogene and its construction and use |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572308A Liver disease treating preparation |
| 02/02/2005 | CN1572301A Tylosin containing antibiotic injection for animals |
| 02/02/2005 | CN1572298A Arbidol containing compound preparation |
| 02/02/2005 | CN1572293A Legalon soft capsule and its preparing method |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187343C Method for production of triazolinethione derivative |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187094C Polyol-IFN-beta conjugates |
| 02/02/2005 | CN1187088C Chimeric flavirirus vaccines |